Noopur Raje, MD

Noopur Raje, MD, is a leading expert in multiple myeloma and plasma cell disorders. She serves as director of the Center for Multiple Myeloma at the Mass General Brigham Cancer Institute and holds the Rita M. Kelley Chair in Oncology. She is also a professor of medicine at Harvard Medical School.

Dr Raje earned her MD from B.J. Medical College, University of Pune, India, and completed her residency at Massachusetts General Hospital, followed by a fellowship at Dana-Farber Cancer Institute.

She founded the Center for Multiple Myeloma at Mass General Brigham Cancer Institute, where she leads a dedicated team of clinical investigators focused on bringing novel cutting-edge treatments to patients. Dr Raje’s translational laboratory efforts include leading pioneering research on the biology of multiple myeloma bone disease and immunotherapies. Her translational research explores the bone marrow microenvironment to identify new therapeutic targets, with the goal of overcoming drug resistance and improving patient outcomes. Her studies also are focused on understanding response and resistance to novel immunotherapies.

A globally recognized leader, Dr Raje is a member of the International Myeloma Working Group and serves as secretary and executive board member of the International Myeloma Society. She also chairs educational committees for the American Society of Clinical Oncology, the American Society of Hematology, and the International Myeloma Society, and she chairs several steering committees for clinical trials.

Dr Raje’s contributions have been recognized through numerous honors, including the Claflin Distinguished Scholar Award (2010), the inaugural Rita M. Kelley Chair in Oncology (2013), the Leukemia & Lymphoma Society Clinical Scholar Award (2017), the Tom Spitzer Clinical Excellence Award (2020), and the Ken Anderson Basic and Translational Science Award (2022). Finally, she is the recipient of multiple research grants, has published extensively in top-tier journals, and is on the editorial boards of several journals.